Prediction of , index 1486
Prospective Prediction
- Prediction Index
- 1486
- Prediction Date
- Commercial Prediction
- partial SUCCESS (commercially sufficient yet moderate clinical benefit with non-inferior-to-FDQ21A-NH anti-ILI efficacy for A/H3N2 for >=65 ysd participants); partial FAILURE (commercially insufficient clinical benefit with inferior-to-FDQ21A-NH anti-ILI efficacy for B/Victoria; B/Yamagata; and A/H1N1 for >=65 ysd participants)
- Technical Prediction
- partial SUCCESS (statistically significant clinical benefit for A/H3N2 for >=65 ysd participants); partial FAILURE (statistically insignificant clinical benefit for B/Victoria; B/Yamagata; and A/H1N1 for >=65 ysd participants)
Readout of
Prediction Validation
- Readout Date
- Prediction To Readout
- 37 days in advance
- Readout Data Interpretation
- numerically higher geometric mean titers for influenza A in both young and elderly age groups and lower geometric mean titers for influenza B in both young and elderly age groups.
- Press Release
- Press Release (finance.yahoo.com)
Prediction Result
- Prediction Accuracy
- Correct Prediction
- Clinical Benefit Conclusion
- statistically significant against placebo yet commercially insufficient (especially for influenza B as we accurately predicted)
- Prediction Classification
- True Negative (TN)